Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma
- PMID: 11040940
- PMCID: PMC1186967
- DOI: 10.1136/mp.53.4.184
Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma
Abstract
Aims: Loss of heterozygosity (LOH) at specific chromosomal regions strongly suggests the existence of tumour suppressor genes at the relevant segment. Frequent LOH on chromosome 5q has been reported in a wide variety of human tumours, including those of the lung. The aim of this study was to screen for LOH and to clarify the location of putative tumour suppressor genes on chromosome 5 implicated in the genesis and/or development of non-small cell lung carcinoma.
Methods: Thirty three patients with advanced non-small cell lung carcinoma were screened for LOH with a panel of 21 microsatellite DNA markers spanning the entire chromosome 5, using semi-automated fluorochrome based methodology.
Results: Twenty of the non-small cell lung carcinoma samples displayed LOH for one or more informative locus. LOH involving only 5q was found in 10 of 14 of the informative samples. Deletions involving 5p only were not present in the samples under study. There was no evidence of microsatellite instability in any of the analysed loci. These results indicate the presence of five distinct segments displaying high frequencies of deletion on chromosome 5, namely: 5q11.2-q12.2, 5q15 (D5S644 locus), 5q22.3-q23.1, 5q31.1, and 5q35.3. Eight of 14 samples had simultaneous interstitial deletions in at least two different regions. Moreover, concomitant deletion of three and four distinct regions was displayed in three of 14 and two of 14, respectively, of the informative samples.
Conclusion: Allelic deletion on chromosome 5 is a frequent event in patients with non-small cell lung carcinoma. These results suggest the involvement of these five regions, either independently or simultaneously, in both lung squamous cell carcinoma and lung adenocarcinoma.
Figures


Similar articles
-
Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma.Chest. 2005 Oct;128(4):2999-3003. doi: 10.1378/chest.128.4.2999. Chest. 2005. PMID: 16236978
-
Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.Br J Cancer. 1996 Dec;74(12):1968-74. doi: 10.1038/bjc.1996.661. Br J Cancer. 1996. PMID: 8980398 Free PMC article.
-
3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.J Pathol. 2001 Nov;195(4):429-34. doi: 10.1002/path.987. J Pathol. 2001. PMID: 11745674
-
Allelic deletion mapping on chromosome 5 in human carcinomas.Oncogene. 1996 Jan 4;12(1):97-102. Oncogene. 1996. PMID: 8552404
-
Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.Arch Pathol Lab Med. 2004 Aug;128(8):880-4. doi: 10.5858/2004-128-880-LOHPOS. Arch Pathol Lab Med. 2004. PMID: 15270615 Review.
Cited by
-
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.Oncotarget. 2016 Oct 4;7(40):65514-65539. doi: 10.18632/oncotarget.11804. Oncotarget. 2016. PMID: 27602772 Free PMC article.
-
LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis.Mol Biol Cell. 2012 Feb;23(4):716-28. doi: 10.1091/mbc.E11-06-0530. Epub 2011 Dec 21. Mol Biol Cell. 2012. PMID: 22190735 Free PMC article.
-
GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.J Cell Mol Med. 2015 Jun;19(6):1245-52. doi: 10.1111/jcmm.12474. Epub 2015 Mar 27. J Cell Mol Med. 2015. PMID: 25818168 Free PMC article.
-
Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.Cancer Res. 2009 Nov 1;69(21):8482-90. doi: 10.1158/0008-5472.CAN-09-1153. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826047 Free PMC article.
-
Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma.J Cancer Res Clin Oncol. 2008 Oct;134(10):1135-41. doi: 10.1007/s00432-008-0379-1. Epub 2008 Apr 2. J Cancer Res Clin Oncol. 2008. PMID: 18386060 Free PMC article.
References
-
- Giaccone G. Oncogenes and antioncogenes in lung tumorigenesis. Chest 1996;109:130S–4S. - PubMed
-
- Tamura G, Ogasawara S, Nishizuka S, et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res 1996;56:612–15. - PubMed
-
- Ogasawara S, Tamura G, Maesawa C, et al. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology 1996;110:52–7. - PubMed
-
- Horrigan SK, Westbrook CA, Kim AH, et al. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 1996;88:2665–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical